We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$610B
AUM Growth
-$181B
Cap. Flow
-$168B
Cap. Flow %
-27.5%
Top 10 Hldgs %
30.63%
Holding
3,114
New
154
Increased
1,364
Reduced
1,248
Closed
171

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.76B
2
LLY icon
Eli Lilly
LLY
+$1.4B
3
BAC icon
Bank of America
BAC
+$1.3B
4
TSLA icon
Tesla
TSLA
+$1.19B
5
WFC icon
Wells Fargo
WFC
+$784M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$6.47B
2
AMZN icon
Amazon
AMZN
+$3.71B
3
YUM icon
Yum! Brands
YUM
+$2.84B
4
CRM icon
Salesforce
CRM
+$2.77B
5
FTV icon
Fortive
FTV
+$2.41B

Sector Composition

Rank Sector Weight
1 Technology 26.06%
2 Healthcare 18.72%
3 Consumer Discretionary 14.62%
4 Financials 10.36%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDMT icon
2626
4D Molecular Therapeutics
FDMT
$609M
$146K ﹤0.01%
18,108
+2,318
+15% +$21K
GOGL
2627
DELISTED
Golden Ocean Group
GOGL
$144K ﹤0.01%
19,269
+7,554
+64% +$75.7K
SHC icon
2628
Sotera Health
SHC
$5.43B
$144K ﹤0.01%
20,984
+8,028
+62% +$133K
WHG icon
2629
Westwood Holdings Group
WHG
$184M
$144K ﹤0.01%
14,900
CSSE
2630
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$144K ﹤0.01%
20,800
+1,300
+7% +$12K
LUNA
2631
DELISTED
Luna Innovations Incorporated
LUNA
$144K ﹤0.01%
32,400
+5,700
+21% +$32.6K
FARM
2632
DELISTED
Farmer Brothers
FARM
$143K ﹤0.01%
30,400
+12,000
+65% +$61.9K
GTES icon
2633
Gates Industrial Corporation Ltd.
GTES
$7B
$143K ﹤0.01%
+14,591
New +$165K
CLAR icon
2634
Clarus
CLAR
$145M
$142K ﹤0.01%
+10,500
New +$204K
EARN
2635
Ellington Residential Mortgage REIT
EARN
$167M
$142K ﹤0.01%
22,955
-9,857
-30% -$78.6K
KVHI icon
2636
KVH Industries
KVHI
$143M
$142K ﹤0.01%
15,400
APVO icon
2637
Aptevo Therapeutics
APVO
$5.16M
0
UDMY
2638
DELISTED
Udemy
UDMY
$141K ﹤0.01%
11,632
-50,794
-81% -$677K
SUNW
2639
DELISTED
Sunworks, Inc.
SUNW
$141K ﹤0.01%
50,400
+4,200
+9% +$11.8K
NGS icon
2640
Natural Gas Services Group
NGS
$474M
$140K ﹤0.01%
13,888
-7,300
-34% -$75K
SPRY icon
2641
ARS Pharmaceuticals
SPRY
$606M
$140K ﹤0.01%
26,500
-139,700
-84% -$688K
STKL
2642
DELISTED
SunOpta
STKL
$140K ﹤0.01%
+15,310
New +$145K
CDZI icon
2643
Cadiz
CDZI
$295M
$139K ﹤0.01%
72,672
+4,100
+6% +$13.8K
AXDX
2644
DELISTED
Accelerate Diagnostics
AXDX
$138K ﹤0.01%
9,028
VHC icon
2645
VirnetX Holding Corp
VHC
$64.8M
$138K ﹤0.01%
5,885
RBBN icon
2646
Ribbon Communications
RBBN
$377M
$137K ﹤0.01%
61,480
+5,399
+10% +$17.1K
RXT icon
2647
Rackspace Technology
RXT
$1.1B
$137K ﹤0.01%
33,439
+10,336
+45% +$60K
TCMD icon
2648
Tactile Systems Technology
TCMD
$537M
$136K ﹤0.01%
17,384
-19,232
-53% -$160K
SPWH icon
2649
Sportsman's Warehouse
SPWH
$46.8M
$135K ﹤0.01%
16,233
+2,692
+20% +$25.5K
DSKE
2650
DELISTED
Daseke, Inc. Common Stock
DSKE
$135K ﹤0.01%
24,939
+2,899
+13% +$18.6K

Similar funds

T. Rowe Price Associates's Q3 2022 Portfolio in Review

As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.

  • T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
  • T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
  • T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
  • T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
  • T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
  • T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
  • T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.

Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.